vladimirsorokin / iStockphoto.com
Watson Laboratories (a subsidiary of Teva) has secured a win at the US Court of Appeals for the Federal Circuit, after the court said Watson did prove that Bayer’s patent claims were obvious.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Bayer, Watson Laboratories, patent, patent infringement, US Court of Appeals for the Federal Circuit, erectile dysfunction